CIK 0001528287 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
NeuroPace Inc
Sign in to watch- Ticker
- NPCE
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 223550230
- Phone
- 6502372700
- Business address
- 455 N. BERNARDO AVENUE, MOUNTAIN VIEW, CA, 94043
- 4 Open-market sale 10% owner sold 16,992 shares at an average $14.02 ($238,231)
- 4 Open-market sale 10% owner sold 485,000 shares at an average $14.49 ($7,026,033)
- 4 Grant or award Chief Medical Officer acquired 12,500 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 12,500 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 52,470 shares (grant or award)
- 4 Open-market sale Chief Medical Officer sold 17,589 shares at an average $15.09 ($265,401)
- 4 Open-market sale Chief Medical Officer sold 13,848 shares at an average $15.09 ($208,965)
- 4 Open-market sale Chief Medical Officer sold 828 shares at an average $15.02 ($12,441)
- 4 Open-market sale Chief Medical Officer sold 13,402 shares at an average $10.12 ($135,668)
- 4 Open-market sale Chief Medical Officer sold 2,730 shares at $10.14 ($27,695)
- 4 Open-market sale Chief Medical Officer sold 11,005 shares at $8.16 ($89,773)
- 4 Open-market sale 10% owner sold 16,167 shares at an average $8.78 ($141,882)
- 4 Open-market sale 10% owner sold 11,171 shares at an average $8.87 ($99,109)
- 4 Open-market sale 10% owner sold 8,314 shares at an average $9.07 ($75,449)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 6 of 10 · 185 filings